News last update:6 Aug 2012

Construction new methionine plant Adisseo in China well on its way

The group Adisseo, a major manufacturer of nutritional feed ingredients, says construction is progressing well on its new, fully integrated Rhodimet AT 88 methionine plant at the Nanjing Chemical Industrial Park, Jiangsu Province, China.

The plant is being built in conjunction with Adisseo’s parent company China National Bluestar
The plant will begin production of methionine in two phases. The first phase is planned for April 2013 with the production of 70,000 tons per year. The plant’s full capacity, 140,000 tons per year, will be realized in the second phase.
The new, fully integrated plant converts basic raw materials such as propylene and sulphur to intermediate products and then to liquid methionine.
Construction began in August 2010. More than 1,200 workers are currently employed in plant construction at the site.
Growth market
Asia and China in particular are the fastest growing areas for poultry production and thus methionine consumption.
This project is totally aligned with Adisseo’s commitment towards occupational safety, sustainable development and environment protection by developing and implementing the best available technologies.
About Adisseo
In October 2011, Adisseo has acquired Innov’ia, one of the European leaders in the design and contract processing of powdered and granulated ingredients for the food, cosmetics, pharmaceuticals and fine chemicals industries.
Through this transaction, Adisseo Group has strengthened its expertise in the formulation of additives, in research and development and in industrial transfer.
With three production sites, 110 salaried staff and a R&D centre, Innov'ia has more than 500 listed clients.
Worldwide, Adisseo Group employs 1,400 people, has 5 research and development divisions and 7 production facilities in France, Spain and in the United States.
Its global distribution network covers more than 2,500 clients in more than 100 countries. In 2010, the group's turnover exceeded €1 billion.

Dick Ziggers

Or register to be able to comment.